[1]
“Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States”, SRM, vol. 14, no. 2, pp. 131–139, Jun. 2020, doi: 10.18148/srm/2020.v14i2.7757.